Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

ABBOTT LABORATORIES Director's Dealing 2014

Mar 4, 2014

29777_dirs_2014-03-04_420c99e8-fa9a-4d68-86f0-5e30de7a2c98.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: ABBOTT LABORATORIES (ABT)
CIK: 0000001800
Period of Report: 2014-02-28

Reporting Person: Contreras Jaime (Senior Vice President)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2014-02-28 Common shares without par value F 3919 $39.79 Disposed 38217 Direct
2014-03-03 Common shares without par value S 4831 $39.366 Disposed 33386 Direct
2014-03-03 Common shares without par value S 650 $39.37 Disposed 32736 Direct
2014-03-03 Common shares without par value S 2000 $39.3810 Disposed 30736 Direct
2014-03-03 Common shares without par value S 600 $39.384 Disposed 30136 Direct

Holdings (Non-Derivative)

Security Shares Ownership
Common shares without par value 20 Indirect
Common shares without par value 16 Indirect
Common shares without par value 63903 Indirect
Common shares without par value 1067 Indirect
Common shares without par value 12081 Indirect

Footnotes

F1: Balance in the Abbott Laboratories Stock Retirement Trust as of February 28, 2014.

F2: Held in the Jaime Contreras Marvan 2006 Living Trust. The reporting person is sole trustee of the trust. The trust is revocable.

F3: The reporting person disclaims beneficial ownership of all securities held by his spouse.

F4: Held in spouse's living trust. The reporting person's spouse is sole trustee of the trust. The trust is revocable. The reporting person disclaims beneficial ownership of these securities.